Safety
-
Acronym List
Table of Contents: Managing the Risks From Medical Product Use: Creating a Risk Management Framework
Previous Section : Bibliography
AAO | American Academy of Ophtholomology |
AAO | American Academy of Ophtholomology |
AARP | American Association of Retired Persons |
AANN | American Association of Neurosciences Nurses |
AANS | American Association of Neurological Surgeons |
AAWG | Aggregate Analysis Working Group |
ACG | American College of Gastroenterology |
ADE | Adverse Drug Event |
ADR | Adverse Drug Reaction |
AERS | Adverse Event Reporting System |
AHCPR | Agency for Health Care Policy and Research |
AIDS | Acquired Immune Deficiency Syndrome |
AMS | Aseptic Meningitis Syndrome |
ANDA | Abbreviated New Drug Application |
APhA | American Pharmaceutical Association |
ASGE | American Society for Gastrointestinal Endoscopy |
BCPT | Breast Cancer Prevention Trial |
BPAC | Blood Products Advisory Committee |
BSE | Bovine Spongiform Encephalopathy |
CBER | Center for Biologics Evaluation and Research |
CDC | Centers for Disease Control and Prevention |
CDER | Center for Drug Evaluation and Research |
CDRH | Center for Devices and Radiological Health |
CEF | Chick Embryo Fibroblast |
CERTS | Centers for Education and Research on Therapeutics |
CGMP | Current Good Manufacturing Practices |
CIOMS | Council for International Organizations of Medical Sciences |
CJD | Creutzfeldt-Jakob Disease |
CNS | Congress of Neurological Surgeons |
CSF | Cerebrospinal Fluid |
CV | Cardiovascular |
DAVDP | Division of Anti-Viral Drug Products |
DIA | Drug Information Association |
DOD | Department of Defense |
DSMB | Data Safety Monitoring Board |
DTC | Direct-to-Consumer |
EIND | Electronic Investigational New Drug Aplication |
EMEA | European Medicines Evaluation Agency |
ENL | Erythema Nodosum Leprosum |
ESTRI | Electronic Standards for the Transfer of Regulatory Information and Data |
EU | European Union |
EWG | Expert Working Group |
FAO | Food and Agriculture Organization of the United Nations |
FD&C | Federal Food, Drug, and Cosmetic Act |
FOI | Freedom of Information |
GAO | General Accounting Office |
GHC | Group Health Cooperative |
GHTF | Global Harmonization Task Force |
GI | Gastrointestinal |
GMP | Good Manufacturing Practices |
GPRD | General Practice Research Database |
GRP | Good Review Practices |
HCFA | Health Care Financing Administration |
HGH | Human Growth Hormone |
HIV | Human Immunodeficiency Virus |
HMO | Health Maintenance Organization |
HRSA | Health Resources and Services Administration |
IAVG | Interagency Vaccine Group |
ICH | International Conference on Harmonisation |
IDE | Investigational Device Exemption |
IGIV | Immune Globulin Intravenous |
IHS | Indian Health Service |
IND | Investigational New Drug |
ISMP | Institute for Safe Medication Practices |
ISO | International Standards Organization |
JAMA | Journal of the American Medical Association |
JCAHO | Joint Commission on Accreditation of Health Care Organizations |
MAPP | Manual of Policies and Procedures |
MAUDE | Manufacturer and User Device Experience |
MDR | Medical Device Reporting |
MEDDRA | Medical Dictionary for Drug Regulatory Affairs |
MERP | Medication Error Reporting and Prevention |
MMR | Measles, Mumps and Rubella Vaccine |
MMWR | Morbidity and Mortality Weekly Report |
MRA | Mutual Recognition Agreement |
MSSO | Maintenance and Support Services Organization |
NACDS | National Association of Chain Drug Stores |
NASPE | North American Society for Pacing and Electrophysiology |
NCC | MERP National Coordinating Council for Medication Error Reporting and Prevention |
NCHS | National Center for Health Statistics |
NCI | National Cancer Institute |
NCL | National Consumers League |
NCPIE | National Council on Patient Information and Education |
NDA | New Drug Application |
NHLBI | National Heart, Lung, and Blood Institute |
NIAID | National Institute of Allergy and Infectious Diseases |
NIH | National Institutes of Health |
NIS | National Inpatient Sample |
NME | New Molecular Entity |
NNMC | National Naval Medical Center |
NPA | National Prescription Audit |
NSAID | Nonsteroidal Anti-Inflammatory Drug |
NSAPB | National Surgical Adjuvant Breast and Bowel Project |
NTDI | National Disease and Therapeutic Index |
OA | Osteoarthritis |
OBRR | Office of Blood Research and Review |
ODAC | Oncologic Drugs Advisory Committee |
ODE | Office of Drug Evaluation |
OEA | Office of External Affairs |
OHA | Office of Health Affairs |
OPDRA | Office of Post-Marketing Drug Risk Assessment |
OSB | Office of Surveillance and Biometrics |
OSHI | Office of Special Health Issues |
OTC | Over the Counter |
PDUFA | Prescription Drug User Fee Act |
PERI | PhRMA Education and Research Institute |
PHA | Public Health Advisory |
PhRMA | Pharmaceutical Research and Manufacturers of America |
PHS | Public Health Service |
PMA | Premarket Approval |
PSC | Postmarket Strategies Committee |
PSUR | Periodic Safety Update Reports |
QA | Quality Assurance |
Q&A | Question and Answer |
QC | Quality Control |
RA | Rheumatoid Arthritis |
RSNA | Radiological Society of North America |
SAMHSA | Substance Abuse and Mental Health Services Administration |
SCVIR | Society for Cardiovascular Interventional Radiology |
SMDA | Safe Medical Devices Act |
SOPP | Manual of Standard Operating Procedures and Policies |
SRS | Spontaneous Reporting System |
SSED | Summary of Safety and Effectiveness Data |
STAMP | Systematic Technology Assessment of Medical Products |
STEPS | System for Thalidomide Education and Prescribing Safety |
TSE | Transmissible Spongiform Encephalopathies |
TSEAC | Transmissible Spongiform Encephalopathies Advisory Committee |
TTTC | Take Time To Care |
USP | U.S. Pharmacopeia |
USUHS | Uniformed Services University of the Health Sciences |
VAERS | Vaccine Adverse Event Reporting System |
VSD | Vaccine Safety Datalink |
WHO | World Health Organization |
-
-